Assessment of swallowing function in patients with head and neck cancer.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 162, doi. 10.1007/s11912-004-0028-z
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2004 AND VI 6 AND IP 2
Results: 15
1
2
Epigenetic alterations in head and neck cancer: Prevalence, clinical significance, and implications.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 152, doi. 10.1007/s11912-004-0027-0
- By:
- Publication type:
- Article
3
Management of cervical metastasis.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 141, doi. 10.1007/s11912-004-0026-1
- By:
- Publication type:
- Article
4
Surgical reconstruction in patients with cancer of the head and neck.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 133, doi. 10.1007/s11912-004-0025-2
- By:
- Publication type:
- Article
5
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 123, doi. 10.1007/s11912-004-0024-3
- By:
- Publication type:
- Article
6
Glutathione analogues in cancer treatment.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 116, doi. 10.1007/s11912-004-0023-4
- By:
- Publication type:
- Article
7
Mammalian target of rapamycin (mTOR) inhibitors.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 111, doi. 10.1007/s11912-004-0022-5
- By:
- Publication type:
- Article
8
Vascular targeting agents.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 103, doi. 10.1007/s11912-004-0021-6
- By:
- Publication type:
- Article
9
Matrix metalloproteinase inhibitors.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 96, doi. 10.1007/s11912-004-0020-7
- By:
- Publication type:
- Article
10
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 88, doi. 10.1007/s11912-004-0019-0
- By:
- Publication type:
- Article
11
New antiangiogenic agents for renal cell carcinoma: Interferon alfa and thalidomide.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 86, doi. 10.1007/s11912-004-0018-1
- By:
- Publication type:
- Article
12
New antiangiogenic agents for renal cell carcinoma: Bevacizumab.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 85, doi. 10.1007/s11912-004-0017-2
- By:
- Publication type:
- Article
13
Literature alert.
- Published in:
- 2004
- Publication type:
- Abstract
14
Web alert.
- Published in:
- Current Oncology Reports, 2004, v. 6, n. 2, p. 77, doi. 10.1007/s11912-004-0015-4
- Publication type:
- Article
15
Duration of chemotherapy in low-versus high-volume metastatic cancer: Should there be a difference?
- Published in:
- 2004
- By:
- Publication type:
- Editorial